NASDAQ : URGN
UroGen Pharma Ltd. — Financial statements
Healthcare · Biotechnology · United States
Last price 33.48 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.64B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
UroGen Pharma Ltd. (URGN) reported revenue of 188.73M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 188.73M | 109.79M | 90.40M | 82.71M | 64.36M | 48.04M |
| Cost of Revenue | 17.28M | 12.45M | 8.88M | 9.36M | 7.65M | 5.16M |
| Gross Profit | 171.46M | 97.34M | 81.52M | 73.35M | 56.70M | 42.88M |
| Selling, General & Admin | 176.85M | 155.10M | 120.05M | 93.27M | 82.84M | 87.53M |
| Research & Development | 61.26M | 67.11M | 57.15M | 45.61M | 52.91M | 47.64M |
| Operating Expenses | 238.11M | 222.20M | 177.20M | 138.89M | 135.74M | 135.18M |
| Operating Income | -66.65M | -124.86M | -95.68M | -65.54M | -79.04M | -92.29M |
| Interest Expense | -16.22M | -15.35M | -12.52M | -14.71M | -8.44M | |
| Interest & Investment Income | 3.96M | 5.96M | 8.90M | 2.64M | 938.00K | 365.00K |
| Other Non Operating Income (Expenses) | -19.20M | -19.17M | -23.64M | -20.71M | -21.49M | -17.44M |
| EBT Excluding Unusual Items | -98.11M | -153.42M | -122.94M | -98.32M | -108.03M | -109.37M |
| Other Unusual Items | -1.10M | |||||
| Pretax Income | -98.11M | -153.42M | -124.04M | -98.32M | -108.03M | -109.37M |
| Income Tax Expense | -472.00K | 78.00K | 2.83M | 3.92M | 1.75M | 1.45M |
| Net Income | -97.64M | -153.49M | -126.87M | -102.24M | -109.78M | -110.82M |
| Net Income to Common | -97.64M | -153.49M | -126.87M | -102.24M | -109.78M | -110.82M |
| Shares Outstanding (Basic) | 49.47M | 48.12M | 42.88M | 28.83M | 22.81M | 22.35M |
| Shares Outstanding (Diluted) | 49.47M | 48.12M | 42.88M | 28.83M | 22.81M | 22.35M |
| EPS (Basic) | -1.97 | -3.19 | -2.96 | -3.55 | -4.81 | -4.96 |
| EPS (Diluted) | -1.97 | -3.19 | -2.96 | -3.55 | -4.81 | -4.96 |
| Free Cash Flow | -159.13M | -162.73M | -97.06M | -76.57M | -87.81M | -85.64M |
| Free Cash Flow Per Share | -3.22 | -3.38 | -2.26 | -2.66 | -3.85 | -3.83 |
| Gross Margin | 90.84% | 88.66% | 90.18% | 88.68% | 88.11% | 89.27% |
| Operating Margin | -35.32% | -113.73% | -105.84% | -79.23% | -122.82% | -192.11% |
| Profit Margin | -51.73% | -139.81% | -140.35% | -123.61% | -170.58% | -230.67% |
| Free Cash Flow Margin | -84.32% | -148.22% | -107.37% | -92.57% | -136.45% | -178.27% |
| EBITDA | -66.34M | -124.56M | -95.35M | -64.73M | -78.12M | -91.46M |
| EBITDA Margin | -35.15% | -113.45% | -105.48% | -78.26% | -121.38% | -190.38% |
| D&A For EBITDA | 308.00K | 307.00K | 329.00K | 802.00K | 924.00K | 831.00K |
| EBIT | -66.65M | -124.86M | -95.68M | -65.54M | -79.04M | -92.29M |
| EBIT Margin | -35.32% | -113.73% | -105.84% | -79.23% | -122.82% | -192.11% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 79.13M | 110.75M | 171.99M | 95.00M | 55.41M | 44.36M |
| Short-Term Investments | 28.84M | 9.71M | 64.70M | 41.97M | 44.56M | 44.78M |
| Cash & Short-Term Investments | 107.97M | 120.46M | 236.69M | 136.97M | 99.96M | 89.14M |
| Receivables | 88.76M | 33.08M | 20.30M | 15.44M | 12.70M | 11.72M |
| Inventory | 24.59M | 16.46M | 9.23M | 5.67M | 4.33M | 4.83M |
| Prepaid Expenses | 12.78M | 14.67M | 8.85M | 10.28M | 11.10M | 7.48M |
| Restricted Cash | 1.33M | 1.35M | 1.08M | 821.00K | 813.00K | 1.23M |
| Total Current Assets | 235.43M | 186.02M | 276.13M | 169.19M | 128.91M | 114.39M |
| Property, Plant & Equipment | 8.22M | 9.09M | 3.79M | 2.36M | 3.75M | 3.15M |
| Long-Term Investments | 5.02M | 4.50M | 675.00K | |||
| Other Long-Term Assets | 8.94M | 5.34M | 765.00K | 2.26M | 2.96M | 1.53M |
| Total Assets | 252.59M | 200.46M | 285.71M | 178.31M | 135.62M | 119.75M |
| Accounts Payable | 15.47M | 12.14M | 10.93M | 6.51M | 5.53M | 5.79M |
| Accrued Expenses | 36.73M | 29.10M | 27.07M | 20.84M | 15.11M | 13.26M |
| Current Portion of Leases | 2.10M | 1.75M | 1.53M | 819.00K | 941.00K | 1.09M |
| Other Current Liabilities | 7.62M | 3.43M | 6.42M | 3.04M | 2.33M | 2.24M |
| Total Current Liabilities | 61.91M | 46.42M | 45.95M | 31.21M | 23.92M | 22.38M |
| Long-Term Debt | 188.73M | 122.21M | 121.73M | 98.55M | 97.54M | |
| Long-Term Leases | 5.30M | 6.12M | 1.65M | 844.00K | 1.59M | 398.00K |
| Other Long-Term Liabilities | 129.04M | 131.18M | 125.18M | 112.92M | 101.94M | 88.56M |
| Total Liabilities | 384.99M | 305.93M | 294.51M | 243.52M | 224.98M | 111.33M |
| Common Stock | 135.00K | 133.00K | 115.00K | 89.00K | 63.00K | 61.00K |
| Additional Paid-In Capital | 865.11M | 854.09M | 797.25M | 614.03M | 487.79M | 475.70M |
| Retained Earnings | -997.64M | -959.72M | -806.22M | -679.35M | -577.10M | -467.32M |
| Comprehensive Income & Other | -2.00K | 19.00K | 56.00K | 12.00K | -107.00K | -25.00K |
| Total Common Equity | -132.40M | -105.47M | -8.80M | -65.21M | -89.36M | 8.41M |
| Shareholders' Equity | -132.40M | -105.47M | -8.80M | -65.21M | -89.36M | 8.41M |
| Total Liabilities & Equity | 252.59M | 200.46M | 285.71M | 178.31M | 135.62M | 119.75M |
| Total Debt | 196.13M | 130.09M | 124.92M | 100.21M | 100.06M | 1.49M |
| Net Cash (Debt) | -88.15M | -9.63M | 116.79M | 41.26M | -100.00K | 88.33M |
| Net Cash Per Share | -1.78 | -0.20 | 2.72 | 1.43 | -0.00 | 3.95 |
| Filing Date Shares Outstanding | 48.88M | 48.68M | 46.09M | 34.12M | 23.44M | 22.67M |
| Total Common Shares Outstanding | 48.87M | 48.35M | 42.23M | 32.49M | 23.13M | 22.46M |
| Working Capital | 173.51M | 139.61M | 230.19M | 137.97M | 104.99M | 92.01M |
| Book Value Per Share | -2.71 | -2.18 | -0.21 | -2.01 | -3.86 | 0.37 |
| Tangible Book Value | -132.40M | -105.47M | -8.80M | -65.21M | -89.36M | 8.41M |
| Tangible Book Value Per Share | -2.71 | -2.18 | -0.21 | -2.01 | -3.86 | 0.37 |
| Machinery | 4.71M | 4.60M | 4.31M | 4.02M | 3.83M | 3.58M |
| Leasehold Improvements | 626.00K | 626.00K | 626.00K | 617.00K | 617.00K | 617.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -97.64M | -153.49M | -126.87M | -102.24M | -109.78M | -110.82M |
| Depreciation & Amortization | 2.64M | 2.41M | 1.19M | 1.71M | 1.82M | 1.77M |
| Other Amortization | 1.75M | |||||
| Asset Writedown & Restructuring Costs | 3.13M | |||||
| Loss (Gain) From Sale of Investments | -485.00K | -1.88M | -2.89M | -1.03M | -498.00K | 476.00K |
| Stock-Based Compensation | 16.11M | 11.96M | 13.11M | 9.34M | 10.58M | 23.11M |
| Other Operating Activities | 5.67M | 3.34M | 13.77M | 12.52M | 13.75M | 13.67M |
| Change in Accounts Receivable | -69.11M | -12.78M | -4.86M | -2.74M | -987.00K | -4.67M |
| Change in Inventory | -17.46M | -7.24M | -3.55M | -1.35M | -362.00K | -2.87M |
| Change in Accounts Payable | 8.98M | 286.00K | 10.89M | 4.16M | 281.00K | 2.00M |
| Change in Income Taxes | 112.00K | 112.00K | 597.00K | 176.00K | 176.00K | 125.00K |
| Change in Other Net Operating Assets | -7.75M | -8.29M | 1.86M | 3.09M | -4.29M | -7.69M |
| Operating Cash Flow | -158.92M | -162.44M | -96.77M | -76.38M | -87.56M | -84.89M |
| Capital Expenditures | -218.00K | -289.00K | -295.00K | -194.00K | -254.00K | -752.00K |
| Investment in Securities | 40.32M | 61.85M | -20.32M | -759.00K | 1.31M | 4.82M |
| Investing Cash Flow | 40.10M | 61.56M | -20.61M | -953.00K | 1.06M | 4.07M |
| Long-Term Debt Issued | 24.49M | 95.78M | ||||
| Long-Term Debt Repaid | -1.85M | |||||
| Net Debt Issued (Repaid) | 62.78M | -1.85M | 24.49M | 95.78M | ||
| Issuance of Common Stock | 42.51M | 41.77M | 151.49M | 68.23M | 1.51M | 72.46M |
| Other Financing Activities | -3.00K | 18.64M | 48.70M | -160.00K | -144.00K | |
| Financing Cash Flow | 105.29M | 39.92M | 194.62M | 116.93M | 97.13M | 72.32M |
| Net Cash Flow | -13.53M | -60.97M | 77.24M | 39.60M | 10.63M | -8.50M |
| Free Cash Flow | -159.13M | -162.73M | -97.06M | -76.57M | -87.81M | -85.64M |
| Free Cash Flow Margin | -84.32% | -148.22% | -107.37% | -92.57% | -136.45% | -178.27% |
| Free Cash Flow Per Share | -3.22 | -3.38 | -2.26 | -2.66 | -3.85 | -3.83 |
| Levered Free Cash Flow | -106.98M | -99.42M | -46.83M | -35.16M | -42.79M | -44.14M |
| Unlevered Free Cash Flow | -96.84M | -89.83M | -39.01M | -25.96M | -39.27M | -44.14M |
| Change in Working Capital | -85.22M | -27.91M | 4.93M | 3.34M | -5.18M | -13.11M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 1.60B | 1.10B | 449.42M | 462.99M | 204.81M | 213.22M |
| Enterprise Value | 1.69B | 1.10B | 317.95M | 409.47M | 183.56M | 104.69M |
| Last Close Price | 32.72 | 23.42 | 10.65 | 15.00 | 8.87 | 9.51 |
| PS Ratio | 8.47 | 9.98 | 4.97 | 5.60 | 3.18 | 4.44 |
| PB Ratio | -10.39 | -51.05 | -7.10 | -2.29 | 25.34 | |
| P/TBV Ratio | 25.34 | |||||
| EV/Sales Ratio | 8.94 | 10.01 | 3.52 | 4.95 | 2.85 | 2.18 |
| Debt / Equity Ratio | -1.48 | -1.23 | -14.19 | -1.54 | -1.12 | 0.18 |
| Net Debt / Equity Ratio | -0.67 | -0.09 | 13.27 | 0.63 | -0.00 | -10.50 |
| Net Debt / EBITDA Ratio | -1.33 | -0.08 | 1.23 | 0.64 | -0.00 | 0.97 |
| Net Debt / FCF Ratio | -0.55 | -0.06 | 1.20 | 0.54 | -0.00 | 1.03 |
| Asset Turnover | 0.82 | 0.45 | 0.39 | 0.53 | 0.50 | 0.40 |
| Inventory Turnover | 1.09 | 0.97 | 1.19 | 1.87 | 1.67 | 1.52 |
| Quick Ratio | 3.18 | 3.31 | 5.59 | 4.88 | 4.71 | 4.51 |
| Current Ratio | 3.80 | 4.01 | 6.01 | 5.42 | 5.39 | 5.11 |
| Return on Equity (ROE) | -211.55% | |||||
| Return on Assets (ROA) | -18.06% | -32.10% | -25.77% | -26.10% | -38.69% | -47.72% |
| Return on Capital Employed (ROCE) | -35.00% | -81.10% | -39.90% | -44.60% | -70.80% | -94.80% |
| Earnings Yield | -6.03% | -14.00% | -28.23% | -22.08% | -53.60% | -51.98% |
| FCF Yield | -9.95% | -14.84% | -21.60% | -16.54% | -42.88% | -40.17% |
| Buyback Yield / Dilution | -4.63% | -12.22% | -48.70% | -26.43% | -2.05% | -2.60% |